Innovative Treatment Solution Flow Neuroscience offers a unique at-home brain stimulation therapy for Major Depressive Disorder, licensed as the only medically approved headset in Europe and the UK, positioning it as a promising solution for mental health providers and clinics seeking non-invasive, home-based depression treatments.

Expanding Clinical Validation Ongoing clinical trials in partnership with Curebase demonstrate a focus on validating the effectiveness of their device, opening opportunities for partnerships with healthcare organizations, research institutions, and insurance providers interested in evidence-based mental health solutions.

Strong Funding Backed Growth With a recent $9 million Series A funding round led by prominent investors like Khosla Ventures, Flow Neuroscience has financial backing to accelerate product development, expand market reach, and form strategic alliances with healthcare and tech companies.

Regulatory Milestones Having secured regulatory approval after extensive development, Flow Neuroscience is well-positioned to penetrate healthcare markets and collaborate with medical providers, insurance companies, and government health agencies focused on innovative depression treatments.

Digital Marketing Capabilities Utilizing advanced digital tools and technologies such as Facebook Pixel, Google Tag Manager, and cloud infrastructure, the company is poised to implement targeted marketing campaigns aimed at healthcare professionals, mental health clinics, and patients seeking accessible at-home therapies.